with Control-IQ+ technology
Uses CGM values to predict and help prevent highs and lows
Day 1 Improvements
Study participants saw a 13% time in range improvement within the first 24 hours.1
Note: Study was conducted using the t:slim X2 insulin pump with Control-IQ technology and Dexcom G6 CGM sensor.
Wearability Like Never Before
The pump is so small that it can be worn almost anywhere,* giving you more options for comfort and wearability than ever before.
Wear it on-body with an adhesive sleeve (sold separately), which is compatible with all infusion sets, including the AutoSoft XC with 5‑inch tubing.
Clip it easily to your clothes, dress, workout gear, or pajamas. Tandem Mobi can be worn almost anywhere.*
The impressively small Tandem Mobi is so discreet that you can simply slip it into the coin pocket of your jeans (yes, it’s that small).
Reconnect.
It’s a snap!
Itʼs easy to temporarily disconnect an infusion set from your Tandem Mobi for showering, hot tubs, or contact sports.
#1 Favorite Pump
You may be able to experience the life-changing benefits of Tandem automated insulin delivery for $0 out of pocket.
Seagrove PWD Survey: Nov. 2024.
Cost per day calculation reflects the average monthly out-of-pocket cost for pump and disposables necessary to utilize Tandem pump therapy over the life of the 48-month pump warranty. Assumes consumption of 10 infusion sets and cartridges per month.
$0 out of pocket claim based on direct orders from Tandem customers with commercial insurance from 1/1/2025-12/31/2025. Data on file. Actual cost may vary and is subject to individual insurance coverage.
See How Easy
Control Can Be
97% of clinical study participants said Control-IQ+ technology is easy to use.2
Note: Study was conducted using the t:slim X2 insulin pump with Control-IQ technology and Dexcom G6 CGM sensor.
Time in Range
with no increase in hypoglycemia3†
Tandem Diabetes Care will contact you with additional information.
Wake Up and Do What Moves You
Control-IQ+ technology includes a dedicated Sleep Activity that uses a narrower and lower range of treatment values to help guard against lows and highs while sleeping.
Diabetes Management that’s Convenient and Discreet
The Tandem Mobi system is controllable with a compatible, personal iPhone,‡ offering next-level convenience and discretion.
CGM Sensors§
The Tandem Mobi system currently integrates with Dexcom G6 and standard Dexcom G7 (10-Day) sensors.
Infusion Sets
The system is compatible with all Tandem infusion sets, so you can choose the length, angle, and material that best fits your lifestyle.
When you pair Tandem Mobi with the standard Dexcom G7 (10-Day) sensor, you can see your readings on your Apple Watch and bolus from your pump — without having your phone with you.^
Maintain control and time in range on the go
Leave your phone behind — one less thing to worry about
Have greater peace of mind
Ready to order the Tandem Mobi system?
* Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.
† With optimized correction factor based on “rule of less than 1600.”
‡ The mobile app requires a compatible iPhone model and operating system (sold separately). Only available to pump users who reside in the United States.
§ CGM sold separately.
^ Precaution: Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 10 meters of the Dexcom G7. Always pair the Dexcom G7 sensor with your Tandem system before pairing with the Dexcom G7 app and Apple Watch. The Tandem system communicates directly with the Dexcom G7 sensor to get CGM readings, and does not communicate with the Dexcom G7 app or Apple Watch. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
References
Note: Studies were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 sensor.
1. Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.
2. Kudva YC, et al. Diabetes Technol Ther. 2021;23(10):673-683.
3. Messer LH, Breton M. Diabetes Technol Ther. 2023;25(12):877-882.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use in individuals 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The Tandem Mobi system with Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater. Control-IQ+ technology is intended for single patient use. Control-IQ+ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Warning: Control-IQ+ technology should not be used by anyone under the age of 2 years old. It should also not be used in patients who require less than 5 units of insulin per day or who weigh less than 20 pounds.
Control-IQ+ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ+ technology if using hydroxyurea. Users of the Tandem Mobi pump and Control-IQ+ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The Tandem Mobi pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit tandemdiabetes.com/safetyinfo for additional important safety information.